APP and Down syndrome: Specifically, we have found that the A peptide, encoded by the amyloid precursor protein (APP) gene that resides on chromosome 21, can induce large, permanent changes in the genome with potentially wide-ranging effects on gene expression, and, thus, on phenotypes in people with Down syndrome.